What are the differences in fracture risk reduction between abaloparatide and teriparatide for patients with osteoporosis?
No direct evidence for the comparative fracture risk reduction between abaloparatide and teriparatide was identified. Differences exist in indirect evidence, suggesting potential benefits with abaloparatide, especially in hip fracture risk.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24361324
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00